4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-003503
CHIEF EXECUTIVE OFFICER bought 27,836 shares at $1.80 ($50,105)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-05-10 | Purchase | +27,836 | $1.80 | $50,105 | 5,153,303 | D |
| Open-market purchases · 27,836 sh · avg $1.80 · $50,105 | |||||||
Loading xslF345X03/ownership.xml…